BeyondSpring Inc
(NASDAQ:BYSI)
$2.91
-0.11[-3.64%]
At close: Feb 8
$3.09
0.1800[6.19%]
After Hours: 9:05AM EDT
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeyondSpring Stock (NASDAQ:BYSI), Quotes and News Summary

BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.

Loading...
Day Range2.880 - 3.10052 Wk Range0.542 - 3.450Open / Close3.090 / 2.910Float / Outstanding23.093M / 38.929M
Vol / Avg.339.171K / 1.016MMkt Cap113.283MP/E-50d Avg. Price1.770
Div / Yield (Forward)- / -%Payout Ratio-Total Float23.093MEPS-1.640
Globe Newswire - Apr 14, 2022, 9:04AM
InvestorsObserver - Dec 23, 2022, 9:18AM
InvestorsObserver - Dec 20, 2022, 7:42AM
InvestorsObserver - Dec 19, 2022, 5:52AM
InvestorsObserver - Dec 13, 2022, 10:13AM
Seeking Alpha - Nov 23, 2022, 5:18PM
InvestorsObserver - Sep 22, 2022, 3:49PM
InvestorsObserver - Jun 1, 2022, 2:19PM
Sector: Health Care.Industry: Biotechnology
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2023-05-01
REV
Q2 2022Est.ActualSurprise
EPS

(EXPECTED) 2023-02-21

REV340.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy BeyondSpring (BYSI) stock?

A

You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeyondSpring's (BYSI) competitors?

Q

What is the target price for BeyondSpring (BYSI) stock?

A

The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeyondSpring (BYSI)?

A

The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does BeyondSpring (BYSI) pay a dividend?

A

There are no upcoming dividends for BeyondSpring.

Q

When is BeyondSpring (NASDAQ:BYSI) reporting earnings?

A

BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.

Q

Is BeyondSpring (BYSI) going to split?

A

There is no upcoming split for BeyondSpring.

Q

What sector and industry does BeyondSpring (BYSI) operate in?

A

BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.